(Corrects paragraph 1 and headline to state that the treatment is for advanced breast cancer, not early-stage breast cancer) Nov 16 (Reuters) – The US Food and Drug Administration approved Roche’s oral treatment for certain patients with estrogen receptor-positive, HER2-negative advanced breast cancer, the regulator said on Monday. (Reporting by Sahil Pandey in Bengaluru; Editing […]
Health
US FDA approves Roche’s oral treatment for advanced breast cancer
Audio By Carbonatix
(Corrects paragraph 1 and headline to state that the treatment is for advanced breast cancer, not early-stage breast cancer)
Nov 16 (Reuters) – The US Food and Drug Administration approved Roche’s oral treatment for certain patients with estrogen receptor-positive, HER2-negative advanced breast cancer, the regulator said on Monday.
(Reporting by Sahil Pandey in Bengaluru; Editing by Shinjini Ganguli)

